Literature DB >> 32292554

Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors.

Zhili Xin1, Martin K Himmelbauer1, J Howard Jones1, Istvan Enyedy1, Rab Gilfillan1, Thomas Hesson1, Kristopher King1, Douglas J Marcotte1, Paramasivam Murugan1, Joseph C Santoro1, Felix Gonzalez-Lopez de Turiso1.   

Abstract

Apoptosis signal-regulating kinase 1 (ASK1) is a key mediator in the apoptotic and inflammatory cellular stress response. To investigate the therapeutic value of modulating this pathway in neurological disease, we have completed medicinal chemistry studies to identify novel CNS-penetrant ASK1 inhibitors starting from peripherally restricted compounds reported in the literature. This effort led to the discovery of 21, a novel ASK1 inhibitor with good potency (cell IC50 = 138 nM), low clearance (rat Cl/Clu = 0.36/6.7 L h-1 kg-1) and good CNS penetration (rat K p,uu = 0.38).
Copyright © 2020 American Chemical Society.

Entities:  

Year:  2020        PMID: 32292554      PMCID: PMC7153032          DOI: 10.1021/acsmedchemlett.9b00611

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  10 in total

Review 1.  In vitro P-glycoprotein efflux ratio can predict the in vivo brain penetration regardless of biopharmaceutics drug disposition classification system class.

Authors:  Ryota Kikuchi; Sonia M de Morais; J Cory Kalvass
Journal:  Drug Metab Dispos       Date:  2013-09-05       Impact factor: 3.922

2.  Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy.

Authors:  Tony S Gibson; Benjamin Johnson; Andrea Fanjul; Petro Halkowycz; Douglas R Dougan; Derek Cole; Steven Swann
Journal:  Bioorg Med Chem Lett       Date:  2017-03-02       Impact factor: 2.823

Review 3.  Therapeutic application of apoptosis signal-regulating kinase 1 inhibitors.

Authors:  Takao Fujisawa
Journal:  Adv Biol Regul       Date:  2017-10-16

Review 4.  The ASK1-MAP kinase cascades in mammalian stress response.

Authors:  Jun Matsukawa; Atsushi Matsuzawa; Kohsuke Takeda; Hidenori Ichijo
Journal:  J Biochem       Date:  2004-09       Impact factor: 3.387

5.  ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1.

Authors:  Hideki Nishitoh; Hisae Kadowaki; Atsushi Nagai; Takeshi Maruyama; Takanori Yokota; Hisashi Fukutomi; Takuya Noguchi; Atsushi Matsuzawa; Kohsuke Takeda; Hidenori Ichijo
Journal:  Genes Dev       Date:  2008-06-01       Impact factor: 11.361

6.  The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis.

Authors:  Takao Fujisawa; Motoo Takahashi; Yuka Tsukamoto; Namiko Yamaguchi; Masayoshi Nakoji; Megumi Endo; Hiroshi Kodaira; Yuki Hayashi; Hideki Nishitoh; Isao Naguro; Kengo Homma; Hidenori Ichijo
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

7.  Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors.

Authors:  Martin K Himmelbauer; Zhili Xin; J Howard Jones; Istvan Enyedy; Kristopher King; Douglas J Marcotte; Paramasivam Murugan; Joseph C Santoro; Thomas Hesson; Kerri Spilker; Joshua L Johnson; Michael J Luzzio; Rab Gilfillan; Felix Gonzalez-Lopez de Turiso
Journal:  J Med Chem       Date:  2019-11-26       Impact factor: 7.446

Review 8.  Apoptosis signal-regulating kinase 1 as a therapeutic target.

Authors:  Yosuke Kawarazaki; Hidenori Ichijo; Isao Naguro
Journal:  Expert Opin Ther Targets       Date:  2014-03-24       Impact factor: 6.902

9.  Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway.

Authors:  Xiaoli Guo; Chikako Harada; Kazuhiko Namekata; Atsushi Matsuzawa; Monsterrat Camps; Hong Ji; Dominique Swinnen; Catherine Jorand-Lebrun; Mathilde Muzerelle; Pierre-Alain Vitte; Thomas Rückle; Atsuko Kimura; Kuniko Kohyama; Yoh Matsumoto; Hidenori Ichijo; Takayuki Harada
Journal:  EMBO Mol Med       Date:  2010-12       Impact factor: 12.137

Review 10.  Clinical Advancements in the Targeted Therapies against Liver Fibrosis.

Authors:  Ruchi Bansal; Beata Nagórniewicz; Jai Prakash
Journal:  Mediators Inflamm       Date:  2016-11-24       Impact factor: 4.711

  10 in total
  1 in total

Review 1.  Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects.

Authors:  Mohammed I El-Gamal; Seyed-Omar Zaraei; Moustafa M Madkour; Hanan S Anbar
Journal:  Molecules       Date:  2022-01-05       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.